1 / 38

The Scientific Facts of Human Embryo Cloning

The Scientific Facts of Human Embryo Cloning. David A. Prentice, Ph.D. Department of Life Sciences Indiana State University, USA. Human Gene Cloning. Cell Cloning. Cell Cloning

coral
Download Presentation

The Scientific Facts of Human Embryo Cloning

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Scientific Facts of Human Embryo Cloning David A. Prentice, Ph.D.Department of Life SciencesIndiana State University, USA

  2. Human Gene Cloning

  3. Cell Cloning Cell Cloning One cell is placed into the dish or well by itself. The cell divides and forms a population of identical cells (cell clones.)

  4. Fertilization vs. Cloning Fertilization vs. Cloning (somatic cell nuclear transfer)

  5. Fertilization vs. Cloning

  6. Dolly

  7. Cloning is unsafe for the clone and the surrogate mother • Our results indicate that even apparently healthy cloned animals can have gene expression abnormalities that are not severe enough to impede development to birth but that may cause subtle physiological abnormalities which could be difficult to detect.” Humpherys D et al.; “Epigenetic instability in ES cells and cloned mice”; Science 293, 95-97; July 6, 2001 • Humpherys D et al.; “Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei”; Proc. Natl. Acad. Sci. USA 99, 12889-12894; October 1, 2002 • A review of all the world’s cloned animals suggests that every one of them is genetically and physically defective. “The widespread problems associated with clones has led to questions as to whether any clone was entirely normal,” Ian Wilmut said. “There is abundant evidence that cloning can and does go wrong and no justification for believing that this will not happen with humans.” “Gene defects emerge in all animal clones”, Sunday Times of London, April 28, 2002 • Dolly the sheep, first cloned mammal: 1 live birth out of 277 cloned embryos (0.4%) • Cloned mice: 5 live births out of 613 cloned embryos (0.8%) 5 live births out of 314 cloned embryos implanted (1.6%) (0.8%; 1 survived) 26 live births out of 312 cloned embryos implanted (8.3%) (4.2%; 13 survived) • Cloned pigs: 5 live births out of 72 cloned embryos implanted (7%) • Cloned goats: 3 live births out of 85 cloned embryos implanted (3.5%) • Cloned cattle: 30 live births out of 496 cloned embryos implanted (6%) (4.8%; 24 survived) • Cloned cat: 1 live birth out of 188 cloned embryos (0.5%); of 87 embryos implanted (1.1%) • Cloned gaur: 1 live birth out of 692 cloned embryos (81 blastocysts) (0.1%) (0%; 0 survived) • Cloned rabbits: 6 live births out of 1852 cloned embryos (0.3%) (0.2%; 4 survived) • Health risk for the surrogate mother—“large offspring syndrome”

  8. Conceptualization of “Therapeutic Cloning”

  9. Human embryo cloning places women at risk Human embryo cloning places women at risk To treat 17 million Diabetes patients in the United States: Collecting 10 eggs/donor (ACT--71 eggs from 7 donors) At generous 20% cloning efficiency (to achieve blastocyst stage) At generous 10% efficiency at initiating ES cell culture Will require minimum of 850 million eggs Will require minimum 85 million women of childbearing age as donors Health risks—High-dose hormone therapy and surgery to obtain eggs risks the donor’s health and future reproductive success Commercial exploitation—disadvantaged women in U.S. and abroad

  10. Therapeutic Cloning Unsuccessful Therapeutic Cloning Unsuccessful “Our results raise the provocative possibility that even genetically matched cells derived by therapeutic cloning may still face barriers to effective transplantation for some disorders.” W.M. Rideout et al., “Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy,” Cell Immediate Early Publication, published online March 8, 2002

  11. ACT experiment with cloned cow tissues ACT experiment with cloned cow tissues Matching cloned tissues Not through use of embryonic stem cells, but by growth of clone to fetal stage before tissue harvesting. “Because cloned cells were derived from early-stage fetuses, this approach is not an example of therapeutic cloning and would not be undertaken in humans.” (emphasis added) Robert Lanza et al.; “Generation of histocompatible tissue using nuclear transplantation,” Nature Biotechnoology, Advance Online Publication, 6/3/02

  12. Cartoon 1

  13. Quotes regarding “therapeutic cloning” Quotes regarding “therapeutic cloning” • “Moreover, because therapeutic cloning requires the creation and disaggregation ex utero of blastocyst stage embryos, this technique raises complex ethical questions.”“CRNT [cell replacement through nuclear transfer, a.k.a. therapeutic cloning] requires the deliberate creation and disaggregation of a human embryo.”“It is true that the techniques developed in CRNT [cell replacement through nuclear transfer, a.k.a. therapeutic cloning] research can prepare the way scientifically and technically for efforts at reproductive cloning.”Robert P. Lanza, Arthur L. Caplan, Lee M. Silver, Jose B. Cibelli, Michael D. West, Ronald M. Green; "The ethical validity of using nuclear transfer in human transplantation"; The Journal of the American Medical Association 284, 3175-3179; Dec 27, 2000. • Thomas Okarma, chief executive officer, Geron Corporation says: “The odds favoring success are vanishingly small, and the costs are daunting.” “It would take thousands of [human] eggs on an assembly line to produce a custom therapy for a single person. The process is a nonstarter, commercially.”(Denise Gellene, “Clone Profit? Unlikely”, Los Angeles Times, May 10, 2002)

  14. Continued Quotes regarding “therapeutic cloning” • “[T]he poor availability of human oocytes, the low efficiency of the nuclear transfer procedure, and the long population-doubling time of human ES cells make it difficult to envision this [therapeutic cloning] becoming a routine clinical procedure…”Odorico JS, Kaufman DS, Thomson JA, “Multilineage differentiation from human embryonic stem cell lines,” Stem Cells 19, 193-204; 2001 • “However, it is unlikely that large numbers of mature human oocytes would be available for the production of ES cells, particularly if hundreds are required to produce each ES line. The technical capability for nuclear transfer would also need to be widely available and this is unlikely. In addition, epigenetic remnants of the somatic cell used as the nuclear donor can cause major functional problems in development, which must remain a concern for ES cells derived by nuclear transfer.” “Although it is possible to customize ES cells by therapeutic cloning or cytoplasmic transfer, it would appear unlikely that these strategies will be used extensively for producing ES cells compatible for transplantation.”(Alan O.Trounson, “The derivation and potential use of human embryonic stem cells”, Reproduction, Fertility, and Development 13, 523-532; 2001)

  15. Continued Quotes regarding “therapeutic cloning” • “Robert Lanza, chief scientist at Advanced Cell Technology in Worcester, Mass., an ardent advocate for both embryonic stem cell studies and therapeutic cloning, agreed that in the course of the political debate, the need for cloning to overcome immune system rejection has been overstated. ‘It’s not all or nothing. You can move ahead.’”San Francisco Chronicle, Monday, March 18, 2002 Page E – 1) • “[John] Gearhart [of Johns Hopkins University] also says that many scientists ‘feel there are ways of getting around [the rejection problem] without the nuclear transfer paradigm.’ ”Constance Holden, “Would cloning ban affect stem cells?”, Science 293, 1025; Aug 10, 2001 • DR. GEARHART: “There is no question in my mind that the possibility exists that if you are doing an egg donor, and nuclear transfer into an egg, that there possibly exists that that cell -- that the embryonic stem cells derived from that could be rejected. Absolutely.”[Dr. John Gearhart; transcript of the April 25, 2002 meeting of the President’s Council on Bioethics; p.47; http://www.bioethics.gov/meetings/200204/0425.doc] • Dr. Irving Weissman, Stanford, told the President's Council on Bioethics on February 13, 2002 that embryonic stem cells from cloned embryos would require immune suppression: “I should say that when you put the nucleus in from a somatic cell, the mitochondria still come from the host.” He concluded, “And in mouse studies it is clear that those genetic differences can lead to a mild but certainly effective transplant rejection and so immunosuppression, mild though it is, will be required for that.”

  16. “Cloning Unnecessary and Obsolete” “Cloning Unnecessary and Obsolete”--leading embryonic stem cell expert • Alan Trounson, Australian embryonic stem cell expert and a leader in the field worldwide, says that stem cell research has advanced so rapidly in the past few months that therapeutic cloning is now unnecessary. “My view is there are at least three or four other alternatives that are more attractive already,” he said.Trounson abandoned his call for therapeutic cloning, saying scientific breakthroughs mean there is now no need for the controversial technique.Professor Trounson said therapeutic cloning faced logistical problems, and that other techniques were showing great promise and offered better options. “I can't see why, then, you would argue for therapeutic cloning in the long term because it is so difficult to get eggs and you've got this issue of (destroying) embryos as well.”“Stem-cell cloning not needed, says scientist”, The Age (Melbourne), pg. 2, July 29, 2002;“Stem-cell research outpaces cloning”, The Australian, pg. 3, July 29, 2002;“Therapeutic cloning no longer necessary: expert”, AAP Newsfeed, July 29, 2002

  17. Leading Causes of Death, U.S., 2000 (Centers for Disease Control)

  18. Regenerative Medicine with Stem Cells

  19. Derivation of Embryonic Stem Cells Method patentedU.S. patent held by Univ. Wisconsin Purported Advantages:1) Proliferate indefinitely2) Form any tissue

  20. Evidence for Embryonic Stem Cell Pluripotency

  21. Promises, Premises, and Published Data… Claims for embryonic stem cells unsubstantiated Current and potential embryonic stem cell problems: • No current clinical treatments • Few successes in animal models • Difficulty in obtaining pure cultures in the dish • Difficult to establish and maintain • Problem of immune rejection • Potential for tumor formation • Genomic instability

  22. Formation of NeuronsfromBone Marrow Stem CellsandPeripheral Blood Stem Cells

  23. Adult stem cells show pluripotent capacity Adult stem cells from bone marrow can form all body tissues--Jiang Y et al.; “Pluripotency of mesenchymal stem cells derived from adult marrow”; Nature 418, 41-49; 4 July 2002 (published online 20 June 2002)Patients receiving hematopoietic stem cell transplant; stem cells also formed liver, skin, digestive tract.--Körbling MK et al.; “Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells”; New England Journal of Medicine 346, 738-746; March 7, 2002A single adult mouse bone marrow stem cell can form functional marrow, blood cells, liver, lung, gastrointestinal tract, skin, heart and skeletal muscle.--Krause DS et al.; “Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell”; Cell 105, 369-377; May 4, 2001Adult stem cells from brain can grow into a wide variety of organs—heart, lung, intestine, kidney, liver, nervous system, muscle, and other tissues.--Clarke et al.; “Generalized potential of adult neural stem cells”; Science 288, 1660-1663, June 2, 2000. Adult stem cells can multiply extensively --Shi S et al.; "Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression"; Nature Biotechnology 20, 587-591; June 2002--Neildez-Nguyen TMA et al.; “Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo”; Nature Biotechnology 20, 467-472; May 2002--Antonchuk J et al.; “HOXB4-induced expansion of adult hematopoietic stem cells ex vivo”; Cell 109, 39-45; April 5, 2002

  24. Adult stem cells effective treating animal models of disease Stroke—Adult bone marrow stem cells or umbilical cord blood stem cells, even delivered intravenously to brain tissue which has suffered stroke damage in rats, provide therapeutic benefit after stroke. The cells appeared to “home” to sites of damage.--Riess P et al.; “Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury”; Neurosurgery 51 published online October 2002; doi:10.1227/01.NEU.0000027826.68845.CF--Li Y et al.; “Human marrow stromal cell therapy for stroke in rat”; Neurology 59, 514-523; August 2002--Zhao L-R et al.; “Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats”, Experimental Neurology 174, 11-20; 2002.--Chen J et al.; “Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats”; Stroke 32, 2682-2688; November 2001 Heart Damage—Bone marrow stem cells injected into heart, blood stream, or “mobilized” from the bone marrow, repair damage after heart attack.--Toma C et al.; “Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart”; Circulation. 105, 93-98; Jan 1/8, 2002--Orlic D et al., “Mobilized bone marrow cells repair the infarcted heart, improving function and survival”; Proceedings of the National Academy of Sciences USA 98, 10344-10349, August 28, 2001.--Jackson KA et al.; “Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells”; Journal of Clinical Investigation 107, 1395-1402; June 2001--Orlic D et al.; “Bone marrow cells regenerate infarcted myocardium”; Nature 410, 701-705; April 5, 2001

  25. Adult Stem Cells Several labs—adult stem cells capable of re-growth and reconnection in spinal cord injury, allowing functional recovery. They "promote functional recovery of paraplegic adult rats and long-distance motor axon regeneration in their completely transected [severed] spinal cords," and showed "dramatic functional improvement and anatomical repair" (Ramon-Cueto et al.; 2000). Transplanted adult stem cells or stimulation of existing cells achieved re-growth of neurons and re-myelination (sheathing) of neurons.*Hofstetter CP et al., “Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery”, Proc Natl Acad Sci USA 99, 2199-2204; Feb 19, 2002*M. Sasaki et al., "Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons," Glia 35, 26-34; July 2001*A. Ramon-Cueto et al., "Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia," Neuron 25, 425-435; Feb 2000.*M.S. Ramer et al.; "Functional regeneration of sensory axons into the adult spinal cord," Nature 403, 312-316; Jan 20, 2000. *Shihabuddin et al.; "Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus," J Neurosci 20, 8727-8735; Dec 2000.*Barnett et al.; "Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons," Brain 123, 1581-1588, Aug 2000*A. Ramon-Cueto et al., "Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glial transplants,” JNeurosci 18, 3803-3815; May 15, 1998 Spinal Cord Injury Embryonic Stem Cells McDonald et al. showed some functional improvement in rats with spinal cord injury, slightly better than no treatment alone. Liu et al. and Brüstle et al. showed that ES cells could form protective myelin sheaths around nerves in rats with spinal cord injury, but they did not show or test for any functional recovery of the animals.*J.W. McDonald et al., "Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord," Nature Medicine 12, 1410-1412, Dec 1999*S. Liu et al., "Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation," Proc. Natl. Acad. Sci. USA 97, 6126-6131; May 23, 2000*O. Brüstle et al., "Embryonic Stem Cell-Derived Glial Precursers: A Source of Myelinating Transplants," Science 285, 754-756, July 30, 1999

  26. Diabetes Adult Stem Cells Scientists “retrained” immune cells to reverse diabetes in mice. The autoimmunity that was previously directed against insulin-secreting cells was reversed, and adult stem cells in the mice formed insulin-secreting cells. The treatment was “…thus able to effect an apparent cure of established Type 1 diabetes in the [diabetic] mouse”.*S. Ryu et al.; "Reversal of established autoimmune diabetes by restoration of endogenous ß cell function,” J. Clin. Invest. 108, 63-72; July 2001Liver or pancreatic adult stem cells grown in culture formed insulin-secreting islets. When injected into diabetic mice, the mice survived without further need of insulin injections.*Abraham et al.; “Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells”; Endocrinology 143, 3152-3161; Aug 2002*Yang L et al.; “In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells”; Proceedings of the National Academy of Sciences USA, Online Early Edition; 10.1073/pnas.122210699; June 4, 2002 *Peck A et al.; “Use of in vitro–generated, stem cell–derived islets to cure type 1 diabetes. How close are we?”; Ann. N.Y. Acad. Sci. 958, 59-68; 2002.*V.K. Ramiya et al.; "Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells," Nature Medicine 6, 278-282, March 2000. Embryonic Stem Cells Researchers reported the conversion of mouse embryonic stem cells into insulin producing pancreatic islet cells. The mouse embryonic stem cells secreted only 1/50th the normal amount of insulin, and diabetic mice implanted with the cells still died.*N. Lumelsky et al.; "Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets," Science 292, 1389-1394; May 18, 2001

  27. Parkinson’s Disease Adult Stem Cells Embryonic Stem Cells Injection of growth protein into brains of Parkinson’s rats caused their neural stem cells to grow, migrate to damage, and begin to replace missing nerve cells. 80% of rats showed a benefit, with no tumor formation.J. Fallon et al.; "In vivo induction of massive proliferation,directed migration, and differentiation of neural cells in the adult mammalian brain," Proc. Natl. Acad. Sci. USA 97, 14686-14691; December 19, 2000 A Chicago Rush Hospital team identified the signal to turn brain stem cells into dopamine neurons, and grafted the cells into brains of Parkinson’s rats, effectively curing the rats’ severe Parkinson symptoms.Experimental Biology meeting, New Orleans, April 2002 An Emory University group implanted retinal cells into brains of advanced Parkinson’s patients, improving their motor function by 50%.American Academy of Neurology conference, Denver, April 18, 2002 Using the patient’s own adult neural stem cells, a group at Los Angeles Cedars-Sinai Medical Center reports a total reversal of symptoms in the first Parkinson’s patient treated.American Association of Neurological Surgeons meeting, April 8, 2002 NIH researchers used gene engineering to enrich mouse ES cells for dopamine neurons. Injected into Parkinson’s rats gave some benefit up to 8 weeks after injection.J-H Kim et al.; “Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease”; Nature 418, 50-56; July 4, 2002 (published online June 20, 2002) Parkinson’s rats injected with embryonic stem cells showed a modest benefit for just over 50% of the rats, but one-fifth (20%) of the rats died of brain tumors caused by the embryonic stem cells.L.M. Bjorklund et al.; "Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model,“ Proc. Natl. Acad. Sci.USA 99, 2344-2349; Feb 19, 2002 (published online Jan 8, 2002)

  28. Current Clinical Uses of Adult Stem Cells • Cancers—Lymphomas, multiple myeloma, leukemias, breast cancer, neuroblastoma, renal cell carcinoma, ovarian cancer • Autoimmune diseases—multiple sclerosis, systemic lupus, rheumatoid arthritis, scleroderma, scleromyxedema, Crohn’s disease • Anemias (incl. sickle cell anemia) • Immunodeficiencies—including first successful human gene therapy • Bone/cartilage deformities—children with osteogenesis imperfecta • Corneal scarring-generation of new corneas to restore sight • Stroke—neural cell implants in clinical trials • Repairing cardiac tissue after heart attack—bone marrow or muscle stem cells from patient • Parkinson’s—retinal stem cells or patient’s own neural stem cells • Growth of new blood vessels—e.g., preventing gangrene • Gastrointestinal epithelia—regenerate damaged ulcerous tissue • Skin—grafts grown from hair follicle stem cells, after plucking a few hairs from patient

  29. Live Patients vs. Dead Mice German researchers successfully used patients’ own adult bone marrow stem cells to repair heart muscle damaged by heart attack. Ten heart-attack patients received their own adult stem cells through a special catheter into their heart, a procedure where the patient can be awake and talk during treatment. Three months later, the patients treated with their bone marrow stem cells showed significant decreases in the areas of heart damage, and damaged areas were significantly smaller than in patients that did not receive stem cells. Hearts of treated patients were also functioning better than hearts of patients who did not receive stem cells. The authors note that their approach represents “a novel and effective therapeutic procedure” for repair of damaged heart muscle, and “For this method of therapy, no ethical problems exist, and no side effects were observed at any point of time.”[Strauer B.E. et al.; “Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans”; Circulation 106; published online before print September 3, 2002, 10.1161/01.CIR.0000034046.87607.1C] Heart cells derived from embryonic stem cells had a tendency to develop irregular beating rhythms. The scientists found that heart cells derived from mouse embryonic stem cells had “easily inducible triggered arrhythmias [abnormal beating rhythms]” and noted that transplant of such cells into an already damaged heart could actually promote abnormal heartbeat. Based on their results with embryonic stem cells, the authors note: “These findings suggest that cells with restricted developmental potential may be more suitable.” Adult stem cells are considered to have more restricted developmental potential.[Zhang Y.M. et al.; “Stem cell-derived cardiomyocytes demonstrate arrhythmic potential”; Circulation 106, 1294-1299; September 3, 2002. (published online before print August 12, 2002, doi:10.1161/01.CIR.0000027585.05868.67)]

  30. The Developmental “Tree”

  31. Concept of adult stem cells circulating between various organsfor repair and maintenance of tissues

  32. Route Stem Cell The stem cell landscape depicted here illustrates the emerging characteristics of adult stem cells that include plasticity in cell fate, diversity of origin, and a multiplicity of tissue potentials. Stem cells (blue) are able to enter diverse tissue compartments from the bloodstream (the stem cell highway) via “on ramps” and generate appropriate cell types in response to homing signals or growth factors depicted on “billboards.” In theory, all choices are reversible. from Blau HM, Brazelton TR, Weimann JM, “The evolving concept of a stem cell: entity or function?”, Cell 105, 829-841, June 29, 2001

  33. Adult Stem Cells More promising alternative for treatments Able to generate virtually all adult tissues Can multiply almost indefinitely, providing numbers sufficient for clinical treatments Proven success in laboratory culture Proven success in animal models of disease Proven success in current clinical treatments Ability to “home in” on damage Avoid problems with tumor formation Avoid problems with transplant rejection Avoid ethical quandary www.stemcellresearch.org

  34. Arguments Against Human Embryo Cloning • No evidence that cloning is necessary or useful for medical treatments • Cloning research will divert resources and delay cures • Banning only implantation is unenforceable • Creates a class of humans who exist only as means to achieve the ends of others • Risking health and exploitation of women • Leading to commodification, commercialization of human life • Gateway to genetic manipulation and control of human beings

  35. Jim Kelly Spinal cord injury

More Related